GL1X · GenesisL1 explorer

MolNFT v2 · #222493 · protein

Crystal structure of selective IRE1a inhibitor 29 at the enzyme active site

8UVL · Serine/threonine-protein kinase/endoribonuclease IRE1: “Crystal structure of selective IRE1a inhibitor 29 at the enzyme active site”. X-ray diffraction at 2.43, 1 ligand (XOE), 4 pockets (best druggability 0.73). MolNFT v2 #222493…

PDB
8UVL
Type
protein
Length
403 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.43
Source
Homo sapiens
Molecule
Serine/threonine-protein kinase/endoribonuclease IRE1
EC
2.7.11.1, 3.1.26.-
UniProt
O75460
Ligands
XOE
Pockets
4 · best druggability 0.73

Structure

x-ray diffraction · resolution 2.43 · 1 distinct chain · 46% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASerine/threonine-protein kinase/endoribonuclease IRE1 (EC 2.7.11.1, 3.1.26.-)protein40346% helix, 14% strandO75460

Ligands and binding sites

  • XOE · 1-phenyl-N-(2,3,6-trifluoro-4-{[(3M)-3-(2-{[(3R,5R)-5-fluoropiperidin-3-yl]amino}pyrimidin-4-yl)pyridin-2-yl]oxy}phenyl)methanesulfonamide · ligand · chains A
  • EDO · 1,2-ethanediol · additive · 8 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14380.730.8342XOE
21080.510.8220empty
31920.500.7627EDO
4510.270.7412EDO

Compared structures

  • O75460 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein KINASE/ENDORIBONUCLEASE… · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.